Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Breakthrough symptoms after switching long-acting injectable paliperidone palmitate from the gluteal to the deltoid site of administration.

× No keyword cloud information.

3 in total

Review 1. Paliperidone Palmitate Long-Acting Injectable Given Intramuscularly in the Deltoid Versus the Gluteal Muscle: Are They Therapeutically Equivalent?

Authors: John Yin; Abby C Collier; Alasdair M Barr; William G Honer; Ric M Procyshyn
Journal: J Clin Psychopharmacol Date: 2015-08 Impact factor: 3.153

2. A single-dose, open-label, parallel, randomized, dose-proportionality study of paliperidone after intramuscular injections of paliperidone palmitate in the deltoid or gluteal muscle in patients with schizophrenia.

Authors: Adriaan Cleton; Stefaan Rossenu; Herta Crauwels; Joris Berwaerts; David Hough; Srihari Gopal; Marielle Eerdekens; An Vandebosch; Bart Remmerie; Marc De Meulder; Clara M Rosso
Journal: J Clin Pharmacol Date: 2014-04-03 Impact factor: 3.126

3. Population pharmacokinetics of intramuscular paliperidone palmitate in patients with schizophrenia: a novel once-monthly, long-acting formulation of an atypical antipsychotic.

Authors: Mahesh N Samtani; An Vermeulen; Kim Stuyckens
Journal: Clin Pharmacokinet Date: 2009 Impact factor: 6.447

3 in total

5 in total

Review 1. The Pharmacokinetics of Second-Generation Long-Acting Injectable Antipsychotics: Limitations of Monograph Values.

Authors: Lik Hang N Lee; Charles Choi; Abby C Collier; Alasdair M Barr; William G Honer; Ric M Procyshyn
Journal: CNS Drugs Date: 2015-12 Impact factor: 5.749

2. Proposing the Use of Partial AUC as an Adjunctive Measure in Establishing Bioequivalence Between Deltoid and Gluteal Administration of Long-Acting Injectable Antipsychotics.

Authors: Lik Hang N Lee; Charles Choi; Pavel Gershkovich; Alasdair M Barr; William G Honer; Ric M Procyshyn
Journal: Eur J Drug Metab Pharmacokinet Date: 2016-12 Impact factor: 2.441

Breakthrough symptoms after switching long-acting injectable paliperidone palmitate from the gluteal to the deltoid site of administration.

Review 1. Paliperidone Palmitate Long-Acting Injectable Given Intramuscularly in the Deltoid Versus the Gluteal Muscle: Are They Therapeutically Equivalent?

2. A single-dose, open-label, parallel, randomized, dose-proportionality study of paliperidone after intramuscular injections of paliperidone palmitate in the deltoid or gluteal muscle in patients with schizophrenia.

3. Population pharmacokinetics of intramuscular paliperidone palmitate in patients with schizophrenia: a novel once-monthly, long-acting formulation of an atypical antipsychotic.

Review 1. The Pharmacokinetics of Second-Generation Long-Acting Injectable Antipsychotics: Limitations of Monograph Values.

2. Proposing the Use of Partial AUC as an Adjunctive Measure in Establishing Bioequivalence Between Deltoid and Gluteal Administration of Long-Acting Injectable Antipsychotics.

Review 3. Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents.

4. Exercise and Worsening of Extrapyramidal Symptoms during Treatment with Long-Acting Injectable Antipsychotics.

5. Pharmacogenetic evaluation to assess breakthrough psychosis with aripiprazole long-acting injection: a case report.